RECRUITING

Global Cardio Oncology Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.

Official Title

Global Cardio Oncology Registry

Quick Facts

Study Start:2022-07-01
Study Completion:2027-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05598879

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * New cardio-oncology consultation for breast cancer patients, or
  2. * New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or
  3. * New cardio-oncology consultation for acute or chronic leukemia patients, or
  4. * New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or
  5. * New cardio-oncology consultations for immune check-point inhibitors cardiac evaluation.
  6. * All patients have to be 18 years old or older
  1. * Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators.
  2. * Minors less than 18 years old.
  3. * Inability or unwillingness to consent to participate

Contacts and Locations

Study Contact

Diego Sadler, MD FACC
CONTACT
5613898833
sadlerd@ccf.org
Rohit Moudgil, MD PhD
CONTACT
216-445-1932
moudgir@ccf.org

Principal Investigator

Diego Sadler, MD FACC
PRINCIPAL_INVESTIGATOR
The Cleveland Clinic

Study Locations (Sites)

Cleveland Clinic Florida
Weston, Florida, 33331
United States

Collaborators and Investigators

Sponsor: The Cleveland Clinic

  • Diego Sadler, MD FACC, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-01
Study Completion Date2027-07-01

Study Record Updates

Study Start Date2022-07-01
Study Completion Date2027-07-01

Terms related to this study

Keywords Provided by Researchers

  • cardiotoxicity
  • Cancer related cardiovascular diseases
  • prospective registry
  • international collaboration
  • social determinants of health
  • health care disparities
  • real world data
  • cardiology-oncology team work

Additional Relevant MeSH Terms

  • Breast Cancer
  • Hematologic Malignancy
  • Immune Checkpoint Inhibitor-Related Myocarditis
  • Cardiotoxicity
  • Cardiovascular Diseases